S0003732

Dolutegravir 10mg disp tab/PAC-90 No CTN


Dolutegravir 10mg dispersible scored tablets, in a bottle pack of 90, without outer carton.
Indicative Price 4.50 USD
Disclaimer: The images shown are for illustration purposes only and may not be an exact representation of the product. “No Generic Photo Available" means that there is not an image available for this product.

General description:
Dolutegravir 10mg dispersible scored tablets, in a bottle pack of 90, without outer carton

Technical specifications:
Each tablet contains dolutegravir sodium equivalent to 10 mg dolutegravir

Therapeutic class:
Dolutegravir is an Integrase Inhibitor

Dosage, Instructions for use:
Please refer to the guideline WHO Model Formulary 2008:
http://apps.who.int/iris/bitstream/handle/10665/44053/9789241547659_eng. pdf?sequence=1
https://www.who.int/publications/i/item/9789241547659
For more details, please see WHO treatment guidelines https://www.who.int/publications/i/item/9789240031593 and WHO Essential Medicines Library https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02 or your regional/national guidelines.

Indications
Management of HIV-1 infection in children and adults in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Shelf life:
24 months

Storage conditions:
Do not store above 30°C.

Component of a KIT:
This item is a component of S9901023 - IEHK2017, PEP kit (S1400651 - Dolutegravir 10mg disp tab/PAC-90 No CTN)

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Related Products